Table 2 Tally of binge-eating events and urges to binge-eat events
From: SipNose-topiramate: a potential novel approach to binge eating management
Total # binges to eat | Total # urges to binge-eat | Number of binges per week Mean (± SD) | Difference from baseline in # binges-eating eventst per week Range (p-value) | Number of binge-eating event days per week Mean (± SD) | Difference from baseline in # binge-eating event days per week Range (p-value) | Number of Urges to Binge-eat Per Week Mean (± SD) | Difference from baseline in # Urge-to-binge-eat per week Range (p-value) | Number of urges to binge-eat days per week Mean (± SD) | Difference from baseline in # urges to binge-eat days per week Range (p-value) | |
|---|---|---|---|---|---|---|---|---|---|---|
Baseline phase | 135 | 71 | 4.9 (± 2.26) | 4.1 (± 1.49) | 2.56 (± 1.66) | 2.12 (± 1.33) | ||||
Treatment phase | 199 | 295 | 1.58 (± 2.23) to 2.67 (± 3.63) | − 2.3 to − 3.4 (p-value 0.0005–0.0034) | 1.32 (± 2.03) to 2.08 (± 2.27) | − 2.8 to − 2.0 (p-value 0.0005–0.005) | 2.20 (± 2.62) to 4.67 (± 3.37) | -0.4 to 2.11 (p-value 0.0176–1) | 1.67 (± 1.72) to 3.25 (± 2.01) | − 0.2 to 1.13 (p-value 0.0420–0.6377) |
Follow-up phase | 64 | 27 | 2.67 (± 3.09) | − 2.3 (± 2.35) | 2.24 (± 2.20) | − 1.8 (± 1.90) | 1.15 (± 1.41) | − 1.4 (± 1.41) | 2.24 (± 2.20) | − 1.1 (± 1.09) |